中性粒细胞与淋巴细胞比值在HPV阳性口咽癌中的预后作用
本研究回顾性分析104例HPV阳性口咽癌患者,按NLR截断值2.42分为低NLR组(n=61)和高NLR组(n=43)。高NLR与晚期T分类(P=.007)和糖尿病(P=.01)相关,且手术为基础的治疗比例更低(20.9% vs 42.6%,P=.02)。高NLR组5年DFS率更低(68.1% vs 94.7%,P=.01),多因素分析显示高NLR是5年DFS不良的独立预后因素(HR=4.16,95%CI 1.24-13.95)。
要点
- 治疗前高NLR与HPV阳性口咽癌患者更差的5年DFS独立相关。
- 高NLR组接受手术为基础治疗的比例更低(20.9% vs 42.6%)。
- 晚期N分类是5年OS和DFS的显著不良预后因素。
核心结论
- 治疗前升高的NLR与HPV阳性口咽癌患者较差的DFS相关。
研究设计与样本
- 回顾性机构数据库分析,纳入104例HPV阳性口咽癌患者,计算治疗前4周内血实验室数据得出的NLR。
主要发现
- 高NLR与更高比例的晚期T分类(P=.007)和糖尿病(P=.01)相关。
- 高NLR组手术为基础治疗比例低于低NLR组(20.9% vs 42.6%,P=.02)。
- 高NLR组5年OS率低于低NLR组(85.3% vs 96.3%,P=.09),5年DFS率更低(68.1% vs 94.7%,P=.01)。
- 多因素分析显示晚期N分类是5年OS不良的显著预测因素(HR=17.40,95%CI 2.36-128.29)。
- 晚期N分类(HR=7.78,95%CI 2.33-25.93)和高NLR(HR=4.16,95%CI 1.24-13.95)是5年DFS不良的重要预后因素。
关键数值与推荐
- NLR截断值为2.42,据此分组:低NLR组61例,高NLR组43例。
临床怎么用
- 治疗前NLR或可作为HPV阳性口咽癌患者DFS的预后评估指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective To investigate the prognostic impact of the neutrophil-to-lymphocyte ratio (NLR) for human papillomavirus-positive oropharyngeal cancer (HPV+ OPC). Study Design Retrospective institutional database analysis. Setting Tertiary referral medical center. Material and Methods In total, 104 patients with HPV+ OPC were enrolled. From the blood laboratory data checked within 4 weeks before initiation of primary treatment, NLR was calculated. The association between clinicopathological characteristics and NLR was analyzed, and the prognostic role was evaluated based on overall survival (OS) and disease-free survival (DFS). Results According to the cutoff value (2.42) for NLR, the patients were classified into the low NLR group (n = 61) or the high NLR group (n = 43). High NLR was associated with a higher rate of advanced T classification ( P = .007) and diabetes mellitus ( P = .01). The proportion of surgery-based treatment was lower in the high NLR group (20.9% vs 42.6%, P = .02). The high NLR group showed a lower 5-year OS rate (85.3% vs 96.3%, P = .09) and a lower 5-year DFS rate (68.1% vs 94.7%, P = .01) than those in the low NLR group. Multivariate analysis showed that advanced N classification was a significant predictor for worse 5-year OS (hazard ratio [HR], 17.40; 95% confidence interval [CI], 2.36-128.29) and that both advanced N classification (HR, 7.78; 95% CI, 2.33-25.93) and high NLR (HR, 4.16; 95% CI, 1.24-13.95) were important prognosticators for worse 5-year DFS. Conclusion Elevated pretreatment NLR was associated with poor DFS in patients with HPV+ OPC.
引用
- So YK, Lee G, Oh D, et al. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients with Human Papillomavirus-Positive Oropharyngeal Cancer. Otolaryngol Head Neck Surg. 2018. PMID: 29557259. doi:10.1177/0194599818764651
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。